GL1X · GenesisL1 explorer

MolNFT v1 · #162350 · protein

Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analogue

6R67: “Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analogue”. X-ray diffraction, 1 ligand (JTE), 3 pockets (best druggability 0.33). MolNFT v1 #162350 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6R67
Type
protein
Length
232 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
JTE
Pockets
3 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1166% helix, 53% strandP02766

Ligands and binding sites

  • JTE · (2~{R})-2-[4-(3,5-dimethylphenyl)-3-fluoranyl-phenyl]propanoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.330.7515empty
2650.290.7315empty
3600.280.7314empty

Interfaces

1 interface between chains.

  • A–B · 919 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 6R67 · Crystal structure of transthyretin in complex with CHF5075, a flurbiprofen analogue · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.